EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor

Júlia Dulsat iD, Raimon Puig de la Bellacasa iD, José I Borrell iD

Molecules · 2024

DOI: 10.3390/molecules29246042 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2024. Verfasst von Júlia Dulsat und 2 weiteren Autor:innen. Beteiligte Einrichtung: Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain. Hauptthemen laut MEDLINE: Protein Kinase Inhibitors, Microsomes, Liver. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia e Innovación, Ministerio de Ciencia e Innovación, Proyectos de “Prueba de Concepto 2022” del Programa Estatal para impulsar la investigación científico-técnica y su transfer….

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In cases in which a rapid metabolism is the cause of an unfavorable pharmacokinetic profile, it is important to determine the Sites of Metabolism (SoMs) of a molecule to introduce the necessary modifications to improve the stability of the compound. The substitution of hydrogen atoms by deuterium atoms has been proposed to ameliorate such properties due to the greater stability of the C-D bonds. IQS016, bearing a 2-phenylamino substituent, is a compound previously described by our group with good biological activity as a discoidin domain receptor (DDR2) inhibitor but suffers from low metabolic stability determined in a test with rat-liver microsomes (less than 50% of the initial compound after 60 min). We have obtained the corresponding 2-(penta-deuterophenyl) analog (IQS016-d5) from aniline-2,3,4,5,6-d5 showing that it has a better metabolic stability than IQS016 and a higher inhibitory effect on isolated tyrosine kinase receptors but not a better 2D in vitro effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Protein Kinase InhibitorsMicrosomes, LiverAnimalsRatsHumansDrug StabilityDeuteriumMolecular StructureTyrosine Kinase Inhibitors

Stichwörter der Autor:innen

deuterationmetabolismpyrido[2,3-d]pyrimidin-7(8H)-onetyrosine kinase inhibitor

Substanzen

Protein Kinase InhibitorsDeuteriumTyrosine Kinase Inhibitors

Autor:innen und Institutionen

  • Grup de Química Farmacèutica, IQS School of Engineering, Universitat Ramon Llull, Via Augusta 390, E-08017 Barcelona, Spain.

ORCID-Profile: Júlia Dulsat, Raimon Puig de la Bellacasa, José I Borrell

Förderung

  • Ministerio de Ciencia e Innovación
  • Ministerio de Ciencia e Innovación, Proyectos de “Prueba de Concepto 2022” del Programa Estatal para impulsar la investigación científico-técnica y su transfer…

Zitieren

APA

Dulsat, J., Puig de la Bellacasa, R., & Borrell, J. I. (2024). The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor. Molecules. https://doi.org/10.3390/molecules29246042

Vancouver

Dulsat J, Puig de la Bellacasa R, Borrell JI. The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor. Molecules. 2024. doi:10.3390/molecules29246042

BibTeX
@article{Dulsat2024,
  author = {Dulsat, Júlia and Puig de la Bellacasa, Raimon and Borrell, José I},
  title = {The Use of a Penta-Deuterophenyl Substituent to Improve the Metabolic Stability of a Tyrosine Kinase Inhibitor},
  journal = {Molecules},
  year = {2024},
  doi = {10.3390/molecules29246042}
}
Kostenlos starten →